Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT01774760
Eligibility Criteria:
Inclusion Criteria:
* Performance status: Karnofsky score 70 or better or WHO performance status 2 or better
* Diagnosis: Histological, cytological and clinical findings are consistent with squamous cell carcinoma of the head and neck
* Primary tumor diameter as determined clinically or from contrast enhanced CT or T1-weighed MRI scan must be at least 15 mm
* Patients with nodal neck metastases of head and neck cancer are eligible
* Mental status: Patients must be able to understand the meaning of the study
* The patient must sign the appropriate Ethical Committee (EC) approved informed consent documents in the presence of the designated staff
* Patient, if female, must not be pregnant or lactating at the time of the study
Exclusion Criteria:
* Patient must have no history of serious haematologic, cardiovascular, liver or kidney disease.
* Patient must have no history of previous chemotherapy or biological therapy or RT for treatment of head and neck cancer.
* Patient must not have an uncontrolled serious infection
* Patients with organ metastases in liver, bone, brain or lung.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01774760
Study Brief:
Protocol Section:
NCT01774760